A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Ulcerative Colitis
Clinical trial NCT01839214 · COMPLETED
Trial details
- NCT number
- NCT01839214
- Sponsor
- Vascular Biogenics Ltd. operating as VBL Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-01
- Primary completion
- 2014-11-01
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.